β2/β3-di- and α/β3-tetrapeptide derivatives as potent agonists at somatostatin sst4 receptors

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 367, Issue 2, 2003, Pages 95-103

  Nunn, Caroline ^a   Rueping, Magnus ^b   Langenegger, Daniel ^a   Schuepbach, Edi ^a   Kimmerlin, Thierry ^b   Micuch, Peter ^b   Hurth, Konstanze ^a   Seebach, Dieter ^b   Hoyer, Daniel ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b ETH ZURICH   (Switzerland)

Author keywords

peptide; cAMP; CCL39 cells; Luciferase; Somatostatin (SRIF); Somatostatin receptor 4 (sst4); SRE

Indexed keywords

ADENYLATE CYCLASE; CGP 23996; FORSKOLIN; LUCIFERASE; PARTIAL AGONIST; PEPTIDE DERIVATIVE; RADIOLIGAND; RECEPTOR SUBTYPE; RECOMBINANT RECEPTOR; SOMATOSTATIN 28; SOMATOSTATIN RECEPTOR; TETRAPEPTIDE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL LINE; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; LUNG FIBROBLAST; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

ADENYLATE CYCLASE; ANIMALS; CELLS, CULTURED; CRICETINAE; CRICETULUS; DIPEPTIDES; ENZYME INHIBITORS; FIBROBLASTS; FORSKOLIN; HUMANS; LIGANDS; LUCIFERASES; LUNG; MEMBRANE PROTEINS; MICE; OLIGOPEPTIDES; RADIOLIGAND ASSAY; RECEPTORS, SOMATOSTATIN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0037292238     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-002-0673-4     Document Type: Article

References (48)

1. Arvidsson PI, Frackenpohl J, Ryder NS, Liechty B, Petersen F, Zimmermann H, Camenisch GP, Woessner R, Seebach D (2001) On the antimicrobial and hemolytic activities of amphiphilic β-peptides. Chem Biochem 2:771-773
2. Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J, Guillemin R (1973) Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179:77-79
3. Cheng RP, Gellman SH, DeGrado WF (2001) β-peptides: from structure to function. Chem Rev 101:3219-3232
4. De Lean A (1979) SCTFIT: a computer program for simultaneous analysis of saturation and competition curves. Howard Hughes Medical Institute, Duke University Medical Center, Durham, North Carolina
5. Epelbaum J, Dournaud P, Fodor M, Viollet C (1994) The neurobiology of somatostatin. Crit Rev Neurobiol 8:25-44
6. Frackenpohl J, Arvidsson PI, Schreiber JV, Seebach D (2001) The outstanding biological stability of β- and γ-peptides toward proteolytic enzymes: an in vitro investigation with fifteen peptidases. Chem Biochem 2:445-455
7. Gademann K, Seebach D (2001) Synthesis of cyclo-β-tripeptides and their biological in vitro evaluation as antiproliferatives against the growth of human cancer cell lines. Helv Chim Acta 84:2924-2937
8. Gademann K, Hintermann T, Schreiber JV (1999a) β-peptides: twisting and turning. Curr Med Chem 6:905-925
9. Gademann K, Ernst M, Hoyer D, Seebach D (1999b) Synthesis and biological evaluation of a cyclo-β-tetrapeptide as a somatostatin analogue. Angew Chem Int Ed (English) 38:1223-1226
10. Gademann K, Ernst M, Seebach D, Hoyer D (2000) The cyclo-β-tetrapeptide (β-Hphe-β-HThr-β-HLys-β-HTrp): synthesis, NMR structure in methanol solution, and affinity for human somatostatin receptors. Helv Chim Acta 83:16-33
11. Gademann K, Kimmerlin T, Hoyer D, Seebach D (2001) Peptide folding induces high and selective affinity of a linear and small β-peptide to the human somatostatin receptor 4. J Med Chem 44:2460-2468
12. Guibourdenche C, Podlech J, Seebach D (1996) Selective acylations of multifunctional nucleophiles, including carbohydrates and nucleosides, with intermediates generated by Wolff rearrangement of amino acid derived diazo ketones: preparation of β-amino acid derivatives. Liebigs Annal 7:1121-1129
13. 3- amino acids and their use as building blocks for the solid-phase synthesis of β-peptides. Helv Chim Acta 81:187-206
14. Hamuro Y, Schneider JP, DeGrado WF (1999) De novo design of antibacterial β-peptides. J Am Chem Soc 121:12200-12201
15. Hannon JP, Nunn C, Stolz B, Bruns C, Weckbecker G, Lewis I, Troxler T, Hurth K, Hoyer D (2002) Drug design at peptide receptors: somatostatin receptor ligands. J Mol Neurosci 18:15-27
16. Hill DJ, Mio MJ, Prince RB, Hughes TS, Moore JS (2001) A field guide to foldamers. Chem Rev 101:3893-4012
17. Hoyer D, Luebbert H, Bruns C (1994) Molecular pharmacology of somatostatin receptors. Naunyn-Schmiedebergs Arch Pharmacol 350:441-453
18. Hoyer D, Bell GI, Berelowitz M, Epelbaum J, Feniuk W, Humphrey PPA, O'Carroll AM, Patel YC, Schonbrunn A, Taylor JE, Reisine T (1995) Classification and nomenclature of somatostatin receptors. Trends Pharmacol Sci 16:86-88
19. Krulich L, Dhariwal AP, McCann SM (1968) Stimulatory and inhibitory effects of purified hypothalamic extracts on growth hormone release from rat pituitary in vitro. Endocrinology 83:783-790
20. Martin JL, Chesselet MF, Raynor K, Gonzales C, Reisine T (1991) Differential distribution of somatostatin receptor subtypes in rat brain revealed by newly developed somatostatin analogs. Neuroscience 41:581-593
21. 2-homotryptophan derivatives for β-peptide synthesis. Helv Chim Acta 85:1567-1577
22. Patel YC (1997) Molecular pharmacology of somatostatin receptor subtypes. J Endocrinol Invest 20:348-367
23. Patel YC (1999) Somatostatin and its receptor family. Front Neuroendocrinol 20:157-198
24. Podlech J, Seebach D (1995) The Arndt-Eistert-reaction in peptide chemistry. A facile access to homopeptides. Angew Chem 107:507-509/Angew Chem Int Ed (English) 34:471-472
25. Podlech J, Seebach D (1995) The Arndt-Eistert-reaction in peptide chemistry. A facile access to homopeptides. Angew Chem 107:507-509/Angew Chem Int Ed (English) 34:471-472
26. Raynor K, Reisine T (1989) Analogs of somatostatin selectively label distinct subtypes of somatostatin receptors in rat brain. J Pharmacol Exp Ther 251:510-517
27. Raynor K, Coy DC, Reisine T (1992) Analogs of somatostatin bind selectively to brain somatostatin receptor subtypes. J Neurochem 59:1241-1250
28. Reubi JC (1984) Evidence for two somatostatin-14 receptor types in rat brain cortex. Neurosci Lett 49:259-263
29. Rohrer SP, Berk SC (1999) Development of somatostatin receptor subtype selective agonists through combinatorial chemistry. Curr Opin Drug Discov Dev 2:293-303
30. Rohrer SP, Schaeffer JM (2000) Identification and characterization of subtype selective somatostatin receptor agonists. J Physiol Paris 94:211-215
31. Rohrer SP, Birzin ET, Mosley RT, Berk SC, Hutchins SM, Shen DM, Xiong Y, Hayes EC, Parmar RM, Foor F, Mitra SW, Degrado SJ, Shu M, Klopp JM, Cai SJ, Blake A, Chan WWS, Pasternak A, Yang L, Patchett AA, Smith RG, Chapman KT, Schaeffer JM (1998) Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry. Science 282:737-740
32. Rueping M, Mahajan Y, Sauer M, Seebach D (2002) Cellularuptake studies with β-peptides. Chem Biochem 3:257-259
33. Schindler M, Kidd EJ, Carruthers AM, Wyatt MA, Jarvie EM, Sellers LA, Feniuk W, Humphrey PPA (1998) Molecular cloning and functional characterization of a rat somatostatin sst2b receptor splice variant. Br J Pharmacol 125:209-217
34. Seebach D, Matthews JL (1997) β-peptides: a surprise at every turn. Chem Commun 2:2015-2022
35. Seebach D, Overhand M, Kühnle FNM, Martinoni B, Oberer L, Hommel U, Widmer H (1996) β-peptides: synthesis by Arndt-Eistert homologation with concomitant peptide coupling. Structure determination by NMR and CD spectroscopy and by X-ray crystallography. Helical secondary structure of a β-hexapeptide in solution and its stability towards pepsin. Helv Chim Acta 79:913-941
36. Seebach D, Abele S, Schreiber JV, Martinoni B, Nussbaum AK, Schild H, Schultz H, Henneke H, Woessner R, Bitsch F (1998) Biological and pharmacokinetic studies with β-peptides. Chimia 52:734-739
37. Seebach D, Abele S, Gademann K, Jaun B (1999) Pleated sheets and turns of β-peptides with proteinogenic side chains. Angew Chem 111:1700-1703/Angew Chem Int Ed (English) 38:1595-1597
38. Seebach D, Abele S, Gademann K, Jaun B (1999) Pleated sheets and turns of β-peptides with proteinogenic side chains. Angew Chem 111:1700-1703/Angew Chem Int Ed (English) 38:1595-1597
39. 3-tetrapeptide derivatives with nanomolar affinities to a human somatostatin receptor. Helv Chem Acta 84:3503-3510
40. Seebach D, Albert M, Arvidsson PI, Rueping M, Schreiber JV (2001b) From the biopolymer PHB to biological investigations of unnatural β- and γ-peptides. Chimia 55:345-353
41. Siehler S, Seuwen K, Hoyer D (1999) Characterisation of human recombinant somatostatin receptors. I. Radioligand binding studies. Naunyn-Schmiedebergs Arch Pharmacol 360:488-499
42. Tran VT, Beal MF, Martin JB (1985) Two types of somatostatin receptors differentiated by cyclic somatostatin analogs. Science 228:492-495
43. Umezawa N, Gelman MA, Haigis MC, Raines RT, Gellman SH (2002) Translocation of a β-peptide across cell membranes. J Am Chem Soc 124:368-369
44. Vanetti M, Kouba M, Wang XM, Vogt G, Hoellt V (1992) Cloning and expression of a novel mouse somatostatin receptor (SSTR2B). FEBS Lett 311:290-294
45. Werder M, Hauser H, Abele S, Seebach D (1999) β-peptides as inhibitors of small-intestinal cholesterol and fat absorption. Helv Chim Acta 82:1774-1783
46. 14C-Labeled β-nonapeptide in rats- in vitro and in vivo pharmacokinetic studies. Biopharm Drug Dispos (in press)
47. Yang L, Berk SC, Rohrer SP, Mosley RT, Alison BH, Birzin ET, Hayes EC, Mitra SW, Parmar RM, Cheng K, Wu TJ, Butler BS, Foor F, Pasternak A, Pan R, Silva M, Freidinger RM, Smith RG, Chapman K, Schaeffer JM, Patchett AA (1998) Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2. Proc Natl Acad Sci USA 95:10836-10841
48. Zhou C, Guo G, Morriello G, Pasternak A, Pan Y, Rohrer SP, Birzin ET, Huskey S-EW, Jacks T, Schleim KD, Cheng K, Schaeffer JM, Patchett AA, Yang L (2001) Nipecotic and isonipecotic amides as potent and selective somatostatin subtype-2 receptor agonists. Bioorg Med Chem Letts 11:415-417